
Jeffrey H. Murray
Examiner (ID: 2022, Phone: (571)272-9023 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1699, 1609 |
| Total Applications | 1761 |
| Issued Applications | 1272 |
| Pending Applications | 9 |
| Abandoned Applications | 485 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5247879
[patent_doc_number] => 20070244113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'COMPOUNDS AND THERAPEUTICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/680843
[patent_app_country] => US
[patent_app_date] => 2007-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 86378
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11680843
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/680843 | COMPOUNDS AND THERAPEUTICAL USE THEREOF | Feb 28, 2007 | Abandoned |
Array
(
[id] => 5063647
[patent_doc_number] => 20070225287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Substituted Arylpyrazines'
[patent_app_type] => utility
[patent_app_number] => 11/675648
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37964
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225287.pdf
[firstpage_image] =>[orig_patent_app_number] => 11675648
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/675648 | Substituted Arylpyrazines | Feb 15, 2007 | Abandoned |
Array
(
[id] => 5005671
[patent_doc_number] => 20070203243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'RESOLUTION OF ALPHA-(PHENOXY) PHENYLACETIC ACID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/675408
[patent_app_country] => US
[patent_app_date] => 2007-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19152
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203243.pdf
[firstpage_image] =>[orig_patent_app_number] => 11675408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/675408 | RESOLUTION OF ALPHA-(PHENOXY) PHENYLACETIC ACID DERIVATIVES | Feb 14, 2007 | Abandoned |
Array
(
[id] => 5070304
[patent_doc_number] => 20070191406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Heterocyclic antiviral compounds'
[patent_app_type] => utility
[patent_app_number] => 11/706728
[patent_app_country] => US
[patent_app_date] => 2007-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24056
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11706728
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/706728 | Heterocyclic antiviral compounds | Feb 14, 2007 | Abandoned |
Array
(
[id] => 33185
[patent_doc_number] => 07790883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Process for the preparation of thiazolopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 10/581143
[patent_app_country] => US
[patent_app_date] => 2007-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5515
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581143 | Process for the preparation of thiazolopyrimidines | Feb 13, 2007 | Issued |
Array
(
[id] => 5474585
[patent_doc_number] => 20090247751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'PROCESS FOR THE PREPARATION OF ZALEPLON AND AN INTERMEDIATE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/280061
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2960
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247751.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280061 | PROCESS FOR THE PREPARATION OF ZALEPLON AND AN INTERMEDIATE THEREOF | Feb 12, 2007 | Abandoned |
Array
(
[id] => 6568912
[patent_doc_number] => 20100234403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/223143
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14971
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234403.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223143 | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | Feb 8, 2007 | Issued |
Array
(
[id] => 5253968
[patent_doc_number] => 20070135424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'SUBSTITUTED PROPENYL PIPERAZINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE'
[patent_app_type] => utility
[patent_app_number] => 11/626215
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19048
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135424.pdf
[firstpage_image] =>[orig_patent_app_number] => 11626215
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/626215 | Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase | Jan 22, 2007 | Issued |
Array
(
[id] => 4572439
[patent_doc_number] => 07858783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Metallic compound and organic electroluminescence device comprising the same'
[patent_app_type] => utility
[patent_app_number] => 11/913196
[patent_app_country] => US
[patent_app_date] => 2007-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6579
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913196 | Metallic compound and organic electroluminescence device comprising the same | Jan 7, 2007 | Issued |
Array
(
[id] => 4965816
[patent_doc_number] => 20080108636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 11/617645
[patent_app_country] => US
[patent_app_date] => 2006-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 42782
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11617645
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/617645 | Inhibitors of bruton's tyrosine kinase | Dec 27, 2006 | Issued |
Array
(
[id] => 6601989
[patent_doc_number] => 20100048897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'PROCESS FOR THE PREPARATION OF SILDENAFIL AND INTERMEDIATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/448425
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6531
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048897.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448425 | Process for the preparation of sildenafil and intermediates thereof | Dec 20, 2006 | Issued |
Array
(
[id] => 4860401
[patent_doc_number] => 20080269251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Substituted Pyrazinone Derivatives as Alpha2C-Adrenoreceptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/091181
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22591
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269251.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091181 | Substituted Pyrazinone Derivatives as Alpha2C-Adrenoreceptor Antagonists | Dec 17, 2006 | Abandoned |
Array
(
[id] => 5297136
[patent_doc_number] => 20090012062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Novel Substituted Pyrazinone Derivatives for Use in Mch-1 Mediated Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/091365
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22277
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012062.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091365
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091365 | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases | Dec 17, 2006 | Issued |
Array
(
[id] => 5374790
[patent_doc_number] => 20090312351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Processes for the Preparation of Alfuzosin'
[patent_app_type] => utility
[patent_app_number] => 12/086994
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2568
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312351.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086994
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086994 | Processes for the preparation of alfuzosin | Dec 13, 2006 | Issued |
Array
(
[id] => 5253945
[patent_doc_number] => 20070135401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Lestaurtinib Crystalline Form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib'
[patent_app_type] => utility
[patent_app_number] => 11/636188
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7818
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636188 | Lestaurtinib Crystalline Form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib | Dec 7, 2006 | Abandoned |
Array
(
[id] => 5343490
[patent_doc_number] => 20090182140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Alicyclic Heterocyclic Compound'
[patent_app_type] => utility
[patent_app_number] => 12/085921
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28639
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20090182140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085921 | Alicyclic Heterocyclic Compound | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5343492
[patent_doc_number] => 20090182142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Aromatic Compound'
[patent_app_type] => utility
[patent_app_number] => 12/085778
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21138
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20090182142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085778 | Aromatic Compound | Nov 29, 2006 | Abandoned |
Array
(
[id] => 4989396
[patent_doc_number] => 20070155737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Heterobicyclic metalloprotease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/602116
[patent_app_country] => US
[patent_app_date] => 2006-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27503
[patent_no_of_claims] => 115
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155737.pdf
[firstpage_image] =>[orig_patent_app_number] => 11602116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/602116 | Heterobicyclic metalloprotease inhibitors | Nov 19, 2006 | Abandoned |
Array
(
[id] => 4989397
[patent_doc_number] => 20070155738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Heterobicyclic metalloprotease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/602140
[patent_app_country] => US
[patent_app_date] => 2006-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77066
[patent_no_of_claims] => 173
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11602140
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/602140 | Heterobicyclic metalloprotease inhibitors | Nov 19, 2006 | Abandoned |
Array
(
[id] => 5178065
[patent_doc_number] => 20070179125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Aminopyrimidines useful as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/600588
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18051
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179125.pdf
[firstpage_image] =>[orig_patent_app_number] => 11600588
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/600588 | Aminopyrimidines useful as kinase inhibitors | Nov 15, 2006 | Abandoned |